BUSINESS OPPORTUNITIES

meet us at
3rd - 6th MAY 2010
BIO 2010 CHICAGO - USA

LAST NEWS
Nov 2009 - DSM/Galenix strategic alliance

Galenix out-licenses drug delivery technologies to DSM Pharmaceutical Products and forms in a strategic alliance : Galenix today announced that it has out-licensed six drug delivery technologies to DSM Pharmaceutical Products, Parsippany, USA. Galenix and DSM have also agreed on a manufacturing alliance, where DSM will be the preferred commercial scale manufacturing partner for Galenix commercial products on a global basis. Galenix and DSM will collaborate on business development opportunities co-marketing the technologies based on the strength of Galenix in drug product development and clinical services, and DSM in process development, industrial scale up and commercial pharmaceutical manufacturing.
2009 - cGMP Agreement for human use

Galenix Pharma has obtained an updated agreement for cGMP manufacturing, importation and ditribution of human and investigational medicinal products AFSSAPS #M09/168
2008 - cGMP Agreement for veterinary use

Galenix Pharma has obtained an agreement for cGMP manufacturing, importation and distribution of veterinary and investigational medicinal products AFSSA #V1515/08

newsletter signup
Subscribe Newsletter Please insert your email adress


indentification user
Forgot password Register

R&D Pipeline Pre-clinical Clinical Batch Phase I Registration Market authorization Launch
Antiacid proton-pump inhibitor Orodispersible delayed tablet - Microgix® Patent & LCM Q2/2008
Antidiabetic and hypolipidemic therapy in association Dispersible tablet - MR dispersible tablet LCM patented Orodispersible/Dispersible Q4/2008
Antidiabetic oral therapy Orodispersible/dispersible tablet - LCM Patent Metformine 500mg, 850mg, 1000mg - Exclusive licence for European Territory November 2007
Antihepileptic therapy ODT/DT patent Q4/2008 Q2/2009 Q2/2008
Antiviral therapy Orodispersible/dispersible tablet - LCM June 2008 Q4/2008
Antiviral therapy XR tablet - LCM Microgix® June 2008
Association of two anti-Alzheimer agents Orodispersible tablet - LCM Patent in force January 2007
Hypolipidemic therapy MR Tablet - LCM Microgix® + Patent Q3/2008
Home - About us - Pharmaceutical Services - Clinical Supplies - Drug delivery - Business Opportunities - News - Job offers - Contact
Copyright © 2010 Galenix - Tous droits réservés